Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS)
at www.tipranks.com (Tue, 4-Aug 1:30 AM)
FDA Grants Priority Review to Agios’ Mitapivat—First Oral PK Activator Advances in Sickle Cell Disease
Market Chameleon (Tue, 7-Jul 11:43 AM)
